Lung cancer is the second most common cancer and the leading cause of cancer-related
death worldwide. Molecular imaging using [18 F] fluorodeoxyglucose Positron Emission …

Lung cancer (LC) still represents one of the most common tumours in both women and men.
PET/CT is a whole-body non-invasive imaging procedure that has been increasingly used …

Background CUPISCO is an ongoing randomized phase II trial (NCT03498521) comparing
molecularly guided therapy versus platinum‐based chemotherapy in patients newly …

Precision medicine is evolving to include a variety of data to optimize patient care and
improve outcome. Multimodality imaging is paving the way toward this goal. PET/CT with 18 …

High-mobility group box 1 (HMGB1) is a versatile protein with intranuclear and extracellular
functions. It is involved in invasion and metastasis in various human malignancies. However …

Introduction: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-
TBNA) is used mostly in patients with non-small cell lung cancer (NSCLC) to sample …

Objectives For diagnosing left adrenal gland metastasis in lung cancer, clinical guidelines
recommend to perform EUS, but EUS-B (EUS using an EBUS-scope) is increasingly being …

The present study aimed to identify a high‑risk population with non‑small cell lung cancer
(NSCLC) and to predict TNM stages using the neutrophil‑to‑lymphocyte ratio (NLR) and the …

Integrated positron emission tomography/computed tomography (PET/CT) using 2-[18 F]
fluoro-2-deoxy-d-glucose (18 F-FDG) has emerged as a powerful tool for combined …

In patients with lung cancer, enlarged or 18Fluoro-deoxyglucose positron emission
tomography (18FDG-PET) positive left adrenal glands are suspected for distant metastases …